Vernalis Share Price (VER)

23.25 -0.13 (-0.53%) delayed: 8:12AM BST

Bid price	23.00	Open price	22.25
Ask price	23.50	Prev close	23.38
High price	22.25	Spread	2.13%
Low price	22.25	Volume	53,621

Register now for FREE live Vernalis share prices, Vernalis stock quotes, charts, trades and FREE Vernalis company fundamentals, market news and much much more. Why not upgrade to a premium service and get Vernalis Level 2 Data, indepth research tools and investor commentary for Vernalis (VER) and other London Stock Exchange equities.

Vernalis Share Price Chart

Advanced Charts >>

Intraday
Historic

You need to upgrade your Flash Player

Vernalis Share Price Information

Name	Vernalis	Epic	VER
Activites	Develops and commercializes pharmaceutical products for a range of medical disorders.	Reuters	VER.L
ISIN	GB00B3Y5L754	Google Finance	LON:VER

Share Price (p)	23.25	Prev. Share Price (p)	23.38
Shares in Issue (m)	442	Market Cap (£m)	103
PE Ratio (x)	-2.56	Div per share (p)	0.00
Div yield (%)	0.00	Div cover (x)
EPS (p)	-7.70	PEG

Vernalis Director Deals

Dec.Date	Type	Director	Pos	No. of Shares
17/08/2011	BUY	Allan Baxter	NED	25,000
12/08/2011	BUY	Ian Garland	CEO	50,000
12/08/2011	BUY	David Mackney	FD	50,000
01/06/2010	BUY	George Kennedy	NED	100,000
13/05/2009	BUY	Ian Garland	CEO	1,111,100

More Vernalis Director Deals >>

Vernalis Company News

12:50 22/05/2012

Result of AGM

/* */ RNS Number : 8525D Vernalis PLC 22 May 2012 22 May 2012 LSE: VER Vernalis Results of Annual General Meeting Resolutions Vernalis plc (LSE: VER) announces that all resolutions proposed to...

09:12 02/05/2012

Vernalis announces success of V81444 Phase 1 trial

Vernalis has announced the successful outcome of its Phase I trial of V81444, its adenosine A2A antagonist with potential application in Parkinson's Disease and other CNS indications. The double-blind, placebo controlled study investigated single and multiple ascending doses and was conducted in...

07:00 02/05/2012

Successful Outcome for V81444 in Phase I Study

/* */ RNS Number : 5277C Vernalis PLC 02 May 2012 2 May 2012 LSE: VER Successful Outcome for V81444 in Phase I Study Vernalis plc today announces the successful outcome of its Phase I trial of V81444, its adenosine A 2A antagonist...

More Vernalis Company News >>

Vernalis Share Price Discussions

more than 1 year ago

New Vernalis (VER)

This is for 2008 -9 (2007 was a year with great hopes and hype, equals a sp about 50p) Reality now is a sp about 4p Yet despite a drug failure ( was it?), they have some products that look interesting - not earth-shattering but a decent pipeline AND some CASH - "wow"! the only Q in my...